Christopher M. Nutting

Papers

Total Citations

H-Index

About

Dr. Christopher M. Nutting is a leading figure in head and neck oncology, with his research fundamentally advancing the surgical management of complex aerodigestive tract cancers. His primary contributions focus on the application and evaluation of transoral robotic surgery (TORS), particularly for recurrent malignancies—a notoriously challenging clinical scenario. In his landmark 2020 systematic review and meta-analysis, Dr. Nutting synthesized global evidence to demonstrate that TORS offers a viable, minimally invasive salvage option for patients with previously treated upper aerodigestive tract cancers. This work, which has garnered over 30 citations, critically assessed survival data and functional outcomes, establishing benchmarks for safety and efficacy in a procedure that remains relatively infrequent but highly impactful. By providing a rigorous evidence base for TORS in recurrent disease, Dr. Nutting’s research has directly influenced surgical decision-making, offering patients a less morbid alternative to traditional open approaches. His commitment to evidence-based innovation continues to shape the standard of care in head and neck surgical oncology, making him a key authority for clinicians and researchers navigating the frontier of robotic surgery.